Critical illness weakness: Common questions

Current Anaesthesia and Critical Care

Volumn 18, Issue 5-6, 2007, Pages 252-260

  Linos, Konstantinos ^a   Foot, Carole ^a   Ziegenfuss, Marc ^a   David Freeman, W ^b   Meng Tan, K ^c  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Critical illness; Critical illness myopathy; Critical illness polyneuropathy; Polyneuropathy

Indexed keywords

ATRACURIUM; CISATRACURIUM; CORTICOSTEROID; DOXACURIUM; IMMUNOGLOBULIN; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PIPECURONIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ARTICLE; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EXCRETION; DRUG MEGADOSE; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MYOPATHY; NONHUMAN; PHYSIOTHERAPY; POLYNEUROMYOPATHY; POLYNEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEAKNESS;

EID: 36549073674     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2007.10.005     Document Type: Article

References (55)

1. Lacomis D., Petrella J.T., and Giuliani M.J. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 21 5 (1998) 610-617
2. Bolton C.F., Gilbert J.J., Hahn A.F., and Sibbald W.J. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47 11 (1984) 1223-1231
3. Bolton C.F., Laverty D.A., Brown J.D., Witt N.J., Hahn A.F., and Sibbald W.J. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 49 5 (1986) 563-573
4. Visser L.H. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol 13 11 (2006) 1203-1212
5. De Jonghe B., Sharshar T., Lefaucheur J.P., Authier F.J., Durand-Zaleski I., Boussarsar M., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 288 22 (2002) 2859-2867
6. Deem S. Intensive-care-unit-acquired muscle weakness. Respir Care 51 9 (2006) 1042-1052 discussion 1052-3
7. Op de Coul A.A., Verheul G.A., Leyten A.C., Schellens R.L., and Teepen J.L. Critical illness polyneuromyopathy after artificial respiration. Clin Neurol Neurosurg 93 1 (1991) 27-33
8. Latronico N., Fenzi F., Recupero D., Guarneri B., Tomelleri G., Tonin P., et al. Critical illness myopathy and neuropathy. Lancet 347 9015 (1996) 1579-1582
9. Lacomis D., Zochodne D.W., and Bird S.J. Critical illness myopathy. Muscle Nerve 23 12 (2000) 1785-1788
10. Latronico N., Peli E., and Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care 11 2 (2005) 126-132
11. Deem S., Lee C.M., and Curtis J.R. Acquired neuromuscular disorders in the intensive care unit. Am J Respir Crit Care Med 168 7 (2003) 735-739
12. Thiele R.I., Jakob H., Hund E., Tantzky S., Keller S., Kamler M., et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery'. Thorac Cardiovasc Surg 48 3 (2000) 145-150
13. Garnacho-Montero J., Madrazo-Osuna J., Garcia-Garmendia J.L., Ortiz-Leyba C., Jimenez-Jimenez F.J., Barrero-Almodovar A., et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27 8 (2001) 1288-1296
14. Leijten F.S., Harinck-de Weerd J.E., Poortvliet D.C., and de Weerd A.W. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 274 15 (1995) 1221-1225
15. Van den Berghe G., Schoonheydt K., Becx P., Bruyninckx F., and Wouters P.J. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64 8 (2005) 1348-1353
16. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
17. Tennila A., Salmi T., Pettila V., Roine R.O., Varpula T., and Takkunen O. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26 9 (2000) 1360-1363
18. Tepper M., Rakic S., Haas J.A., and Woittiez A.J. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med 56 6 (2000) 211-214
19. Witt N.J., Zochodne D.W., Bolton C.F., Grand'Maison F., Wells G., Young G.B., et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 99 1 (1991) 176-184
20. Berek K., Margreiter J., Willeit J., Berek A., Schmutzhard E., and Mutz N.J. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 22 9 (1996) 849-855
21. Banwell B.L., Mildner R.J., Hassall A.C., Becker L.E., Vajsar J., and Shemie S.D. Muscle weakness in critically ill children. Neurology 61 12 (2003) 1779-1782
22. Bolton C.F. Neuromuscular manifestations of critical illness. Muscle Nerve 32 2 (2005) 140-163
23. Hund E.F., Fogel W., Krieger D., DeGeorgia M., and Hacke W. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 24 8 (1996) 1328-1333
24. Maher J., Rutledge F., Remtulla H., Parkes A., Bernardi L., and Bolton C.F. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 21 9 (1995) 737-743
25. van Mook W.N., and Hulsewe-Evers R.P. Critical illness polyneuropathy. Curr Opin Crit Care 8 4 (2002) 302-310
26. Zifko U.A., Zipko H.T., and Bolton C.F. Clinical and electrophysiological findings in critical illness polyneuropathy. J Neurol Sci 159 2 (1998) 186-193
27. Zochodne D.W., Bolton C.F., Wells G.A., Gilbert J.J., Hahn A.F., Brown J.D., et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110 Part 4 (1987) 819-841
28. Coakley J.H., Nagendran K., Honavar M., and Hinds C.J. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 19 6 (1993) 323-328
29. Bolton C.F., and Young G.B. The neurological consultation and neurological syndromes in the intensive care unit. Baillieres Clin Neurol 5 3 (1996) 447-475
30. de Letter M.A., Visser L.H., van der Meche F.G., Ang W., and Savelkoul H.F. Distinctions between critical illness polyneuropathy and axonal Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 68 3 (2000) 397-398
31. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248 11 (2001) 929-934
32. Gooch J.L., Suchyta M.R., Balbierz J.M., Petajan J.H., and Clemmer T.P. Prolonged paralysis after treatment with neuromuscular junction blocking agents. Crit Care Med 19 9 (1991) 1125-1131
33. Segredo V., Caldwell J.E., Matthay M.A., Sharma M.L., Gruenke L.D., and Miller R.D. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 327 8 (1992) 524-528
34. Fenzi F., Latronico N., Refatti N., and Rizzuto N. Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol (Berl) 106 1 (2003) 75-82
35. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360 9328 (2002) 219-223
36. Fischer J.R., and Baer R.K. Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents. Ann Pharmacother 30 12 (1996) 1437-1445
37. Bednarik J., Vondracek P., Dusek L., Moravcova E., and Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol 252 3 (2005) 343-351
38. Strange C., Vaughan L., Franklin C., and Johnson J. Comparison of train-of-four and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med 156 5 (1997) 1556-1561
39. de Letter M.A., Schmitz P.I., Visser L.H., Verheul F.A., Schellens R.L., Op de Coul D.A., et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 29 12 (2001) 2281-2286
40. Lacomis D., Smith T.W., and Chad D.A. Acute myopathy and neuropathy in status asthmaticus: case report and literature review. Muscle Nerve 16 1 (1993) 84-90
41. DuBois D.C., and Almon R.R. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 4 5 (1981) 370-373
42. Segredo V., Caldwell J.E., Matthay M.A., Sharma M.L., Gruenke L.D., and Miller R.D. Persistent paralysis in critically ill patients after long-term administration of vecuronium. Engl J Med 327 8 (1992) 524-528
43. Partridge B.L., Abrams J.H., Bazemore C., and Rubin R. Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 18 10 (1990) 1177-1179
44. Marshall I.G., Gibb A.J., and Durant N.N. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. Br J Anaesth 55 8 (1983) 703-714
45. Murray M.J., Cowen J., DeBlock H., Erstad B., Gray Jr. A.W., Tescher A.N., et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 30 1 (2002) 142-156
46. Rudis M.I., Sikora C.A., Angus E., Peterson E., Popovich Jr. J., Hyzy R., et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med 25 4 (1997) 575-583
47. Mohr M., Englisch L., Roth A., Burchardi H., and Zielmann S. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23 11 (1997) 1144-1149
48. Garnacho-Montero J., Amaya-Villar R., Garcia-Garmendia J.L., Madrazo-Osuna J., and Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 33 2 (2005) 349-354
49. van der Schaaf M., Beelen A., and de Groot I.J. Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disabil Rehabil 22 17 (2000) 808-810
50. van der Schaaf M., Beelen A., and de Vos R. Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil 26 20 (2004) 1189-1197
51. de Seze M., Petit H., Wiart L., Cardinaud J.P., Gaujard E., Joseph P.A., et al. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur Neurol 43 2 (2000) 61-69
52. Zifko U.A. Long-term outcome of critical illness polyneuropathy. Muscle Nerve Suppl 9 (2000) S49-S52
53. Fletcher S.N., Kennedy D.D., Ghosh I.R., Misra V.P., Kiff K., Coakley J.H., et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31 4 (2003) 1012-1016
54. Latronico N., Shehu I., and Seghelini E. Neuromuscular sequelae of critical illness. Curr Opin Crit Care 11 4 (2005) 381-390
55. Bolton CF, Chen R, Wijdicks EFM, Zifko UA. Diseases of the peripheral nervous system. In: Neurology of breathing. Philadelphia: Butterworth-Heineman (Elsevier); 2004. p. 165-226.